XT
CELU icon

XTX Topco’s Celularity CELU Stock Holding History

XTX Topco’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,811
Closed -$17K – 4194
2026
Q1 		$17K Sell
12,811
-16,504
-56% -$20.9K ﹤0.01% 3590
2025
Q4 		$32.5K Buy
+29,315
New +$52.6K ﹤0.01% 2945
2025
Q3 		– Sell
-21,452
Closed -$42K – 2639
2025
Q2 		$42K Buy
21,452
+11,057
+106% +$20.1K ﹤0.01% 2048
2025
Q1 		$18K Buy
+10,395
New +$19.7K ﹤0.01% 2166
2024
Q1 		– Sell
-3,417
Closed -$8.46K – 1881
2023
Q4 		$8.46K Buy
3,417
+75
+2% +$163 ﹤0.01% 1442
2023
Q3 		$7.42K Buy
+3,342
New +$12K ﹤0.01% 1439
2022
Q4 		– Sell
-1,235
Closed -$29K – 1157
2022
Q3 		$29K Buy
+1,235
New +$37.5K 0.01% 1053

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

XTX Topco's CELU Position: Q2 2026 in Review

XTX Topco sold out of Celularity (CELU) in Q2 2026, closing a stake of 12,811 shares — an estimated $17K sold.

XTX Topco first reported a position in CELU in Q3 2022 and held it in 7 quarters. The position peaked at $42K in Q2 2025. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • XTX Topco reported no remaining Celularity position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 12,811 Celularity shares in Q2 2026, an estimated $17K.
  • XTX Topco first reported a position in Celularity in Q3 2022 and held it in 7 quarters.
  • XTX Topco's Celularity position peaked at $42K in Q2 2025.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.